drugset / Trial / NCT02264067
Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the pharmacokinetics and safety of WAL2014 capsules administered orally as a single dose to healthy adult male volunteers in double blind manner.
Timeline
- Start
- 1998-07
- Primary completion
- 1998-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talsaclidine | Small molecule | — | Oral |
Indications
No indication recorded.